74  Total SME IPOs listed in 2025

3,229.50 Crs.  Total funds raised in 2025

50  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

74  Total SME IPOs listed in 2025

3229.50 Crs.  Total funds raised in 2025

50  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

74  Total SME IPOs listed in 2025

3229.50 Crs.  Total funds raised in 2025

50  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

74  Total SME IPOs listed in 2025

3229.50 Crs.  Total funds raised in 2025

50  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

Astec LifeSciences IPO (Astec LifeSciences Limited IPO) Detail

Astec LifeSciences Limited is an Chemical - Speciality based company, located in Mumbai, Astec LifeSciences Limited IPO size was 61.50 Cr. and was issued at 82.00 per share. The share of Astec LifeSciences Limited were listed at 83.90 per share and are currently trading at 806.10 per share.

Type :
Sub Sector : Business Of Agrochemicals And Pharmaceuticals
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
93.72 Cr.

PAT :
10.72 Cr.

Pricing Report

Issue Price :
82.00

Listing Price :
83.90

Current Market Price :
806.10

Issue Price vs CMP :
724.1 (883.05%)

listing Price vs CMP :
722.2 (860.79%)

Performance Report (CAGR* wise)

CAGR : 15.82
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Astec LifeSciences

Company Information
Astec LifeSciences Limited specializes in the manufacture and sale of intermediates, active ingredients, and formulations in the off-patent proprietary category, with a particular focus on the agrochemical and pharmaceutical industries. Its manufacturing operations are based in Maharashtra, India, across three units: one in Dombivli and two in Mahad (Unit 1 and Unit 2).

The company commenced its manufacturing journey in August 1994, acquiring a sick unit in Dombivli with an installed capacity of 120 MT for producing Dicap, a pharmaceutical intermediate. To facilitate expansion, the company entered into an agreement with Behram Chemicals Private Limited on February 18, 2002, for utilizing and operating their manufacturing facilities located at B-16, Mahad Industrial Area, in Raigad, Maharashtra.

The facility previously operated by Behram Chemicals was
Show More
Object of Issue
  • Expansion of their existing manufacturing facilities at Mahad, Maharashtra
  • Expansion of their existing Research and Development facility at Dombivli, Maharashtra
  • Meeting Registration expenses
  • Meeting long-term working capital requirements
  • General Corporate Purposes
  • Issue Expenses

Astec LifeSciences MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Nov, 2009
IPO Size :
61.50 Cr.
IPO Subscription :
1.56 X     
PE Multiple :
7.21
Merchant Banker :
Idbi Capital Market Services Limited
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other MainBoard IPOs in Mumbai

Scoda Tubes Limited

  manufacturer of stainless-steel tubes and pipes

  Ahmedabad


Prostarm Info Systems Limited

  designing, manufacturing, and selling Energy Storage and Power Conditioning Equipment

  Mumbai


Aegis Vopak Terminals Limited

  Owns and operates storage terminals for liquefied petroleum gas (LPG)

  Surat


Leela Hotels - Schloss Bangalore Limited

  luxury hospitality company operating under "The Leela" brand in India

  New Delhi



Peer Companies Of This Sector

FAQs

Astec LifeSciences operates in Chemical - Speciality and Business Of Agrochemicals And Pharmaceuticals. The Issue is listed on BSE,NSE in Nov, 2009. Astec LifeSciences IPO size was 61.50 Cr. with Issue price of 82.00 .

Merchant Banker(s) of Astec LifeSciences IPO: Idbi Capital Market Services Limited , Almondz Global Securities Limited

Astec LifeSciences IPO subscription was 1.56 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Astec LifeSciences IPO listed at a listing price of 83.90 against the offer price of 82.00.

The current market price of Astec LifeSciences is 806.10.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency